Highlights

Stock Price Target

 
Search
Recent Price Targets: [Sign In or Register (FREE) to view]
 
SGX: IHH       IHH HEALTHCARE BERHAD
Last Price Avg Target Price   Upside/Downside Price Call
1.84 1.95     +0.11 (5.98%)
* Average Target Price, Price Call and Upside/Downside are derived from Price Targets in the past 6 months.
** Price Targets are adjusted for Bonus Issue, Shares Split & Shares Consolidation (where applicable).
Date Open Price Target Price Upside/Downside Price Call Source News
28/11/2018 1.58 1.95 +0.37 (23.42%) BUY UOB KayHian Price Target News


Price Target Research Article/News (past 6 months)
28/11/2018  UOB KayHian IHH Healthcare - 9M18 Earnings Boosted by Increasingly Mature Greenfield Hospitals



  2 people like this.
 
edcheong A stock to add to your portfolio in these bad times.
26/07/2012 14:44
Stephen Lee Beaware of this stock which is listed in SGX and KLSE. These are cronies political stock which was owned by our one timed former PM Mathier. The crossed border listing of stocks on both side of SGX and KLSE was closed by former PM Dr. Mathier due to the financial crisis in 1997. Backgorund...who control Parkmay the forerunner of IHH? Whom was Vincent Tan of Berjaya Group whom has recently stepped down are the runner for Big Boss....Who is the Big Boss whose office is registerd in Bangsar, K.L. Please do some reflection.
02/08/2012 05:39
moven00 Eventhough IHH is a little political shares I supposed, but I am thinking this is better than Genting SP for the moment.
Better buy uptrending shares than to buy a downtrend shares.
Just my 2 cents opinion.
Huat ahhhh...
28/08/2012 23:32
tand3 These Sor Hai credit Suisse analyst, misleading people with its target price.

Kindly take note their tp is in MYR not Sin dollar ya. Hence, 3.75 is in RINGGIT MALAYSIA not Sin dollar.

Do your own homework, that's what I can say.
31/08/2012 11:44
moven00 Aha, Now CIMB are more decent. 1.53 is logic, but like the Average Target Price 2.22......
Well, Long term IHH will definitely create value for its shareholders.
The journey have just begin....
04/09/2012 01:18
Jlrh8122 It shd be gd to kp long term....
08/09/2012 19:54
michelle zheng Grossly overvalued stock. If politics is a factor, price should be artificially inflated come election but know when to get out or u will be left holding an overweight baby for a long long time. Hope dividend will make up for it then. Good luck to all invested.
29/09/2012 14:07
sh2383jbt They are two healthcare stock listed SGX, is good for long term under ur portfolio. Raffles medical small but growing slowly , compare PE, IHH is highest.
24/10/2012 23:07
9696_88 what happen drop heavily?
28/08/2013 14:21
inphyy IHH Healthcare may be threatened by a decline in Indonesian patients

HEALTHCARE | Staff Reporter,
Singapore Published: 2 hours 57 min ago

According to CIMB, it thinks that since only 18% of total patients admitted to PPL Singapore come from Indonesia, the net contribution from this group is only about 3% of the group’s PATMI, considering (i) domestic patients’revenue intensity has increase sharply, (ii) more than half of the cases from Indonesian patients are non-elective treatments and (iii) larger contributions from other markets dilute its sensitivity to this risk.

Here's more from CIMB:

2Q13 and 1H13 core earnings were in line, accounting for 22% and 37% of our FY13 numbers. However, we cut FY13-15 estimates by 7-9% as we see more start-up and other opex costsgoing forward.

Our SOP-based target price is reduced as a result. We keep our Outperform rating as we expect a more robust ramp-up of the group’s global operations.

Marked improvement
2Q13 core net profit was driven by growth at its new hospitals, savings in finance costs and the recapitalisation of Acibadem. This offset the depreciation and finance costsrelating to new hospitals that had to be recognised in the P&L after completion.

There was a one-off RM22m tax credit in 2Q13 relating to the tax reversal in Singapore.

There was a marked improvement in the average revenue per inpatient at all of its hospitals in Singapore, Malaysia and Turkey. Excluding the accounting treatment for REIT, all of its business segments recorded revenue growth both yoy and sequentially.

Novena, as predicted, broke even on an EBITDA level in 2Q13. We expect an EBITDA breakeven point for Acibadem Bodrum sometime in 4Q13.
28/08/2013 18:03
inphyy IHH's Q2 profit falls 61% to RM156.8m

Patmi plummets as last year's earnings were boosted by medical suites sale
28/08/2013 18:39
Alex Gray Healthcare provider IHH Healthcare Berhad (SGX: Q0F) slipped by 5.4% to S$1.48. Its second quarter results were also released yesterday evening and they aren’t pretty. Quarterly revenue declined by 38% year-on-year to RM1.68b while profits sank 61% to RM157m.
SGX Stock Picks | Singapore Stock Recommendations | Best Shares to Buy @ (http://goo.gl/chE0k2)
28/08/2013 19:08


134  85  188  684 

ActiveGainersLosers
Top 10 Active Counters
 NameLastChange 
 STI ETF 3.14+0.038 
 NikkoAM-STC A.. 1.107+0.008 
 CIMBASEAN40 US$ 9.350.00 
 PHIL AP DIV R.. 1.002+0.007 
 Ezion 0.053+0.003 
 LION-PHILLIP .. 0.984+0.003 
 Nikko AM STI ETF 3.22+0.04 
 HSI25200MBePW.. 0.099-0.029 
 MMP Resources^ 0.007+0.002 
 HSI24988VTePW.. 0.113-0.035 

TOP ARTICLES

1. ATFX Market Update - 2018.12.12 ATFX News Update
2. Research Reports : 11th December 2018 Singapore Stock Market News
3. Telecom Sector: Dialing Up the Heat SGX Stocks and Warrants
4. 2018 XIRR Performance & Networth Updates A Path to Forever Financial Freedom
5. Research Reports : 10th December 2018 Singapore Stock Market News
Partners & Brokers